High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury

Frontiers in Neurology

Volumn FEB, Issue , 2012, Pages

  Wilkinson, Charles W ^a,b   Pagulayan, Kathleen F ^a,b   Petrie, Eric C ^a,b   Mayer, Cynthia L ^a,b   Colasurdo, Elizabeth A ^a   Shofer, Jane B ^b   Hart, Kim L ^a   Hoff, David ^a   Tarabochia, Matthew A ^a   Peskind, Elaine R ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Blast; Concussion; Growth hormone; Hypopituitarism; Pituitary; Traumatic brain injury

Indexed keywords

EID: 84865979851     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00011     Document Type: Article

References (107)

1. Agha, A., Rogers, B., Sherlock, M., O'Kelly, P., Tormey, W., Phillips, J., and Thompson, C. J. (2004a). Anterior pituitary dysfunction in survivors of traumatic brain injury. J. Clin. Endocrinol. Metab. 89, 4929-4936.
2. Agha, A., Thornton, E., O'Kelly, P., Tormey, W., Phillips, J., and Thompson, C. J. (2004b). Posterior pituitary dysfunction after traumatic brain injury.J. Clin. Endocrinol. Metab. 89, 5987-5992.
3. Agha, A., Sherlock, M., Phillips, J., Tormey, W., and Thompson, C. J. (2005). The natural history of post-traumatic neurohypophysial dysfunction. Eur. J. Endocrinol. 152, 371-377.
4. Agha, A., and Thompson, C. J. (2005). High risk of hypogonadism after traumatic brain injury: clinical implications. Pituitary 8, 245-249.
5. Aimaretti, G., Ambrosio, M. R., Di Somma, C., Fusco, A., Cannavò, S., Gasperi, M., Scaroni, C., De Mari-nis, L., Benvenga, S., degli Uberti, E. C., Lombardi, G., Mantero, F., Martino, E., Giordano, G., and Ghigo, E. (2004). Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin. Endocrinol. (Oxf.) 61, 320-326.
6. Aimaretti, G., Ambrosio, M. R., Di Somma, C., Gasperi, M., Cannavò, S., Scaroni, C., Fusco, A., Del Monte, P., De Menis, E., Faustini-Fustini, M., Grimaldi, F., Logoluso, F., Raz-zore, P., Rovere, S., Benvenga, S., degli Uberti, E. C., De Marinis, L., Lombardi, G., Mantero, F., Martino, E., Giordano, G., and Ghigo, E. (2005). Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J. Clin. Endocrinol. Metab. 90, 6085-6092.
7. American Congress of Rehabilitation Medicine. (1993). Definition of mild traumatic brain injury. J. Head Trauma Rehabil. 8, 86-87.
8. Bavisetty, S., McArthur, D. L., Dusick, J. R., Wang, C., Cohan, P., Boscardin, W. J., Swerdloff, R., Levin, H., Chang, D. J., Muizelaar, J. P., and Kelly, D. F. (2008). Chronic hypopituitarism after traumatic brain injury: risk assessment and relationship to outcome. Neurosurgery 62, 1080-1093; discussion 1093-1084.
9. Behan, L. A., and Agha, A. (2007). Endocrine consequences of adult traumatic brain injury. Horm. Res. 68(Suppl. 5), 18-21.
10. Behan, L. A., Phillips, J., Thompson, C. J., and Agha, A. (2008). Neuroen-docrine disorders after traumatic brain injury. J. Neurol. Neurosurg. Psychiatr. 79, 753-759.
11. Berg, C., Oeffner, A., Schumm-Draeger, P. M., Badorrek, F., Brabant, G., Ger-bert, B., Bornstein, S.,Zimmermann, A., Weber, M., Broecker-Preuss, M., Mann, K., and Herrmann, B. L. (2010). Prevalence of anterior pituitary dysfunction in patients following traumatic brain injury in a German multi-centre screening program. Exp. Clin. Endocrinol. Diabetes 118, 139-144.
12. Blair, J. C. (2010). Prevalence, natural history and consequences of post-traumatic hypopituitarism: a case for endocrine surveillance. Br. J. Neurosurg. 24, 10-17.
13. Bondanelli, M., De Marinis, L., Ambrosio, M. R., Monesi, M., Valle, D., Zatelli, M. C., Fusco, A., Bianchi, A., Farneti, M., and Degli Uberti, E. C. (2004). Occurrence of pituitary dysfunction following traumatic brain injury. J. Neurotrauma 21, 685-696.
14. Bushe, C., Sniadecki, J., Bradley, A. J., and Poole Hoffmann, V. (2010). Comparison of metabolic and pro-lactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia. J. Psychopharmacol. (Oxford) 24, 1001-1009.
15. Bushnik, T., Englander, J., and Katznel-son, L. (2007). Fatigue after TBI: association with neuroendocrine abnormalities. Brain Inj. 21, 559-566.
16. Byerly, M., Suppes, T., Tran, Q. V., and Baker, R. A. (2007). Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives. J. Clin. Psychopharmacol. 27, 639-661.
17. Campbell, A. (2010). Oxytocin and human social behavior. Pers. Soc. Psychol Rev. 14, 281-295.
18. Carboni, L., Negri, M., Michielin, F., Bertani, S., Fratte, S. D., Oliosi, B., and Cavanni, P. (2011). Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release. Int. J. Neuropsychopharmacol. doi: 10.1017/S1461145711000824. [Epub ahead of print].
19. Coccaro, E. F., Kavoussi, R. J., Hauger, R. L., Cooper, T. B., and Ferris, C. E (1998). Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch. Gen. Psychiatry 55, 708-714.
20. Colao, A. (2008). The GH-IGF-I axis and the cardiovascular system: clinical implications. Clin. Endocrinol. (Oxf.) 69, 347-358.
21. Colao, A., Di Somma, C., Savanelli, M. C., De Leo, M., and Lombardi, G. (2006a). Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Growth Horm. IGF Res. 16(Suppl.A),S41-48.
22. Colao, A., Di Somma, C., Spiezia, S., Rota, F., Pivonello, R., Savastano, S., and Lombardi, G. (2006b). The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. J. Clin. Endocrinol. Metab. 91, 2191-2200.
23. Corneli, G., Di Somma, C., Prodam, E, Bellone, J., Bellone, S., Gasco, V., Baldelli, R., Rovere, S., Schneider, H. J., Gargantini, L., Gastaldi, R., Ghiz-zoni, L., Valle, D., Salerno, M., Colao, A., Bona, G., Ghigo, E., Maghnie, M., and Aimaretti,G. (2007). Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur. J. Endocrinol. 157, 701-708.
24. Corona, G., Mannucci, E., Jannini, E. A., Lotti, F., Ricca, V., Monami, M., Boddi, V., Bandini, E., Baler-cia, G., Forti, G., and Maggi, M. (2009). Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction. J. Sex. Med. 6, 1457-1466.
25. de Kloet, C. S., Vermetten, E., Geuze, E., Wiegant, V. M., and Westenberg, H. G. (2008). Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder. J. Psychiatr. Res. 42, 192-198.
26. Department of Veterans Affairs/Department of Defense. (2009). VA/DoD Clinical Practice Guideline for Management of Concussion/Mild Traumatic Brain Injury (mTBI). Washington, DC: Department of Veterans Affairs, Department of Defense.
27. Doty, R. L., Marcus, A., and Lee, W. W. (1996). Development of the 12-item cross-cultural smell identification test (CC-SIT). Laryngoscope 106, 353-356.
28. Dusick, J. R., Wang, C., Cohan, P., Swerdloff, R., and Kelly, D. F. (2008). Chapter 1: pathophysiol-ogy of hypopituitarism in the setting of brain injury. Pituitary. doi: 10.1007/s1 1102-008-0130-6. [Epub ahead of print].
29. Englander, J., Bushnik, T., Oggins, J., and Katznelson, L. (2010). Fatigue after traumatic brain injury: association with neuroendocrine, sleep, depression and other factors. Brain Inj. 24, 1379-1388.
30. Falleti, M. G., Maruff, P., Burman, P., and Harris, A. (2006). The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology 31, 681-691.
31. Faul, M., Xu, L., Wald, M. M., and Coro-nado, V G. (2010). Traumatic Brain Injury in the United States: Emergency DepartmentVisits, Hospitaliza-tions and Deaths 2002-2006. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
32. Goekoop, J. G., De Winter, R. F., Wolterbeek, R., Spinhoven, P., Zit-man, F. G., and Wiegant, V M. (2009). Reduced cooperativeness and reward-dependence in depression with above-normal plasma vasopressin concentration. J. Psychopharmacol. (Oxford) 23, 891-897.
33. Götherström, G., Bengtsson, B.-Å., Bosaeus, I., Johannsson, G., and Svensson, J. (2007a). A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J. Clin. Endocrinol. Metab. 92, 1442-1445.
34. Götherström, G., Bengtsson, B.-Å., Bosaeus, I., Johannsson, G., and Svensson, J. (2007b). Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. Eur. J. Endocrinol. 156, 55-64.
35. Götherström, G., Elbornsson, M., Stibrant-Sunnerhagen, K., Bengtsson, B.-Å., Johannsson, G., and Svensson, J. (2009). Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults. J. Clin. Endocrinol. Metab. 94,809-816.
36. Guerrero, A. F., and Alfonso, A. (2010). Traumatic brain injury-related hypopituitarism: a review and recommendations for screening combat veterans. Mil. Med. 175, 574-580.
37. Haddad, P. M., and Wieck, A. (2004). Antipsychotic-induced hyperpro-lactinaemia: mechanisms, clinical features and management. Drugs 64,2291-2314.
38. Hadjadj, S., Faure-Gerard, C., Ragot, S., Millet, C., Duengler, F., Torre-mocha, F., Chatellier, G., Bataille, B., and Marechaud, R. (2007). Diagnostic strategy for growth hormone deficiency: relevance of IGF-1 determination as a screening test. Ann. Endocrinol. (Paris) 68, 449-455.
39. Hartman, M. L., Crowe, B. J., Biller, B. M. K., Ho, K. K., Clemmons, D. R., and Chipman, J. J. (2002). Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J. Clin. Endocrinol. Metab. 87, 477-485.
40. Heinrichs, M., Von Dawans, B., and Domes, G. (2009). Oxytocin, vasopressin, and human social behavior. Front. Neuroendocrinol. 30, 548-557.
41. High, W M. Jr., Briones-Galang, M., Clark, J. A., Gilkison, C., Mossberg, K. A., Zgaljardic, D. J., Masel, B. E., and Urban, R. J. (2010). Effect of growth hormone replacement therapy on cognition after traumatic brain injury. J. Neurotrauma 27, 1565-1575.
42. Ho, K. K. Y. (2007). Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European society for pediatric endocrinology, Lawson Wilkins society, European society of endocrinology, Japan endocrine society, and endocrine society of Australia. Eur. J. Endocrinol. 157, 695-700.
43. Holmin, S., and Mathiesen, T. (1999). Long-term intracerebral inflammatory response after experimental focal brain injury in rat. Neuroreport 10, 1889-1891.
44. Holt, R. I. (2008). Medical causes and consequences of hyperprolacti-naemia. A context for psychiatrists. J. Psychopharmacol. (Oxford) 22, 28-37.
45. Inder, W .J., and Castle, D. (2011). Antipsychotic-induced hyperpro-lactinaemia. Aust. N. Z. J. Psychiatry 45, 830-837.
46. Juul, A., Kastrup, K. W., Pedersen, S. A., and Skakkebaek, N. E. (1997). Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. J. Clin. Endocrinol. Metab. 82, 1195-1201.
47. Kasturi, B. S., and Stein, D. G. (2009). Traumatic brain injury causes long-term reduction in serum growth hormone and persistent astrocy-tosis in the cortico-hypothalamo-pituitary axis of adult male rats. J. Neurotrauma 26, 1315-1324.
48. Kelestimur, F., Tanriverdi, F., Atmaca, H., Unluhizarci, K., Selcuklu, A., and Casanueva, E E (2004). Boxing as a sport activity associated with isolated GH deficiency. J. Endocrinol. Invest. 27, RC28-RC32.
49. Kelly, D. F., Gonzalo, I. T., Cohan, P., Berman, N., Swerdloff, R., and Wang, C. (2000). Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J. Neu-rosurg. 93, 743-752.
50. Kelly, D. F., MacArthur, D. L., Levin, H., Swimmer, S., Dusick, J. R., Cohan, P., Wang, C., and Swerdloff, R. (2006). Neurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, mo derate, or severe traumatic brain injury. J. Neurotrauma 23, 928-942.
51. Klose, M., Juul, A., Struck, J., Mor-genthaler, N. G., Kosteljanetz, M., and Feldt-Rasmussen, U. (2007). Acute and long-term pituitary insufficiency in traumatic brain injury: a prospective single-centre study. Clin. Endocrinol. (Oxf.) 67, 598-606.
52. Kokshoorn, N. E.,Smit,J.W., Nieuwlaat, W. A., Tiemensma, J., Bisschop, P. H., Groote Veldman, R., Roelfsema, E, Franken, A. A., Wassenaar, M. J., Biermasz, N. R., Romijn, J. A., and Pereira, A. M. (2011). Low prevalence of hypopituitarism after traumatic brain injury: a multicen-ter study. Eur. J. Endocrinol. 165, 225-231.
53. Kokshoorn, N. E., Wassenaar, M. J., Biermasz, N. R., Roelfsema, F., Smit, J. W., Romijn, J. A., and Pereira, A. M. (2010). Hypopituitarism following traumatic brain injury: prevalence is affected by the use of different dynamic tests and different normal values. Eur. J. Endocrinol. 162,11-18.
54. Krahulik, D., Zapletalova, J., Frysak, Z., and Vaverka, M. (2010). Dysfunction of hypothalamic-hypophyseal axis after traumatic brain injury in adults. J. Neurosurg. 113, 581-584.
55. Kreitschmann-Andermahr, I., Poll, E. M., Reineke, A., Gilsbach, J. M., Brabant, G., Buchfelder, M., Fass-bender, W., Faust, M., Kann, P. H., and Wallaschofski, H. (2008). Growth hormone deficient patients after traumatic brain injury - baseline characteristics and benefits after growth hormone replacement - an analysis of the German KIMS database. Growth Horm. IGF Res. 18, 472-478.
56. Leal-Cerro, A., Flores, J. M., Rin-con, M., Murillo, F., Pujol, M., Garcia-Pesquera, F., Dieguez, C., and Casanueva, F. F. (2005). Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury. Clin. Endocrinol .(Oxf.) 62, 525-532.
57. Lieberman, S. A., Oberoi, A. L., Gilki-son, C. R., Masel, B. E., and Urban, R. J. (2001). Prevalence of neu-roendocrine dysfunction in patients recovering from traumatic brain injury.J. Clin. Endocrinol. Metab. 86, 2752-2756.
58. Lu, J., Goh, S. J., Tng, P. Y., Deng, Y. Y., Ling, E. A., and Moochhala, S. (2009). Systemic inflammatory response following acute traumatic brain injury. Front. Biosci. 14, 3795-3813.
59. Maghnie, M., Aimaretti, G., Bellone, S., Bona, G., Bellone, J., Baldelli, R., De Sanctis, C., Gargantini, L., Gastaldi, R., Ghizzoni, L., Secco, A., Tinelli, C., and Ghigo, E. (2005). Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur. J. Endocrinol. 152, 589-596.
60. Maric, N. P., Doknic, M., Pavlovic, D., Pekic, S., Stojanovic, M., Jasovic-Gasic, M., and Popovic, V. (2010). Psychiatric and neuropsychologi-cal changes in growth hormone-deficient patients after traumatic brain injury in response to growth hormone therapy. J. Endocrinol. Invest. 33, 770-775.
61. Martínez-Martín, P., Gil-Nagel, A., Gra-cia, L. M., Gómez, J. B., Martínez-Sarriés, J., and Bermejo, F. (1994). Unified Parkinson's disease rating scale characteristics and structure. The Cooperative Multicentric Group. Mov. Disord. 9, 76-83.
62. Masel, B. E. (2004). Rehabilitation and hypopituitarism after traumatic brain injury. Growth Horm. IGF Res. 14(Suppl.A),S108-S113.
63. Masel, B. E. (2005). Traumatic brain injury induced hypopituitarism: the need and hope of rehabilitation. Pituitary 8,263-266.
64. McGauley, G. A. (1989). Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr. Scand. Suppl. 356, 70-72; discussion 73-74.
65. Merali, Z., Kent, P., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M. O., Bédard, T., and Anisman, H. (2006). Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol. Psychiatry 59, 594-602.
66. Military Health System. (2011). DoD Worldwide Numbers for Traumatic Brain Injury. Available at: http://www.health.mil/Research/TBI_Numbers.aspx [accessed].
67. Montgomery, J., Winterbottom, E., Jes-sani, M., Kohegyi, E., Fulmer, J., Seamonds, B., and Josiassen, R. C. (2004). Prevalence of hyperpro-lactinemia in schizophrenia: association with typical and atypical antipsychotic treatment. J. Clin. Psychiatry 65,1491-1498.
68. Mossberg, K. A., Masel, B. E., Gilki-son, C. R., and Urban, R. J. (2008). Aerobic capacity and growth hormone deficiency after traumatic brain injury. J. Clin. Endocrinol. Metab. 93,2581-2587.
69. National Center for Injury Prevention and Control. (2003). Report to Congress on Mild Traumatic Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem. Atlanta, GA: Centers for Disease Control and Prevention.
70. Park, K. D., Kim, D. Y., Lee, J. K., Nam, H.-S., and Park, Y.-G. (2010). Anterior pituitary dysfunction in moderate-to-severe chronic traumatic brain injury patients and the influence on functional outcome. Brain Inj. 24, 1330-1335.
71. Pavlovic, D., Pekic, S., Stojanovic, M., Zivkovic, V., Djurovic, B., Jovanovic, V., Miljic, N., Medic-Stojanoska, M., Doknic, M., Miljic, D., Djurovic, M., Casanueva, F., and Popovic, V. (2010). Chronic cognitive sequelae after traumatic brain injury are not related to growth hormone deficiency in adults. Eur. J. Neurol. 17, 696-702.
72. Popovic, V., Pekic, S., Pavlovic, D., Maric, N., Jasovic-Gasic, M., Djurovic, B., Medic Stojanoska, M., Zivkovic, V., Stojanovic, M., Doknic, M., Milic, N., Djurovic, M., Dieguez, C., and Casanueva, F. F. (2004). Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress. J. Endocrinol. Invest. 27, 1048-1054.
73. Powner, D. J., Boccalandro, C., Alp, M. S., and Vollmer, D. G. (2006). Endocrine failure after traumatic brain injury in adults. Neurocrit. Care 5, 61-70.
74. Prodam, F., Pagano, L., Corneli, G., Golisano, G., Belcastro, S., Busti, A., Gasco, V., Beccuti, G., Grottoli, S., Di Somma, C., Colao, A., Ghigo, E., and Aimaretti, G. (2008). Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiency. J. Endocrinol. Invest. 31, 6-11.
75. Purba, J. S., Hoogendijk, W. J., Hof-man,M.A.,andSwaab,D. F. (1996). Increased number of vasopressin-and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch. Gen. Psychiatry 53, 137-143.
76. R Development Core Team (2011). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: http://www.R-project.org/
77. Regal, M., Páramo, C., Sierra, S. M., and García-Mayor, R. V. (2001). Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin. Endocrinol. (Oxf.) 55, 735-740.
78. Reimunde, P., Quintana, A., Cas-tanon, B., Casteleiro, N., Vilarnovo, Z., Otero, A., Devesa, A., Otero-Cepeda, X. L., and Devesa, J. (2011). Effects of growth hormone (GH) replacement and cognitive rehabilitation in patients with cognitive disorders after traumatic brain injury. Brain Inj. 25, 65-73.
79. Rosén, T., Wirén, L., Wilhelmsen, L., Wiklund, I., and Bengtsson, B.-Å. (1994). Decreased psychological well-being in adult patients with growth hormone deficiency. Clin. Endocrinol. (Oxf.) 40, 111-116.
80. Schneider, H. J., Schneider, M., Kreitschmann-Andermahr, I., Tuschy, U., Wallaschofski, H., Fleck, S., Faust, M., Renner, C. I. E., Kopczak, A., Saller, B., Buchfelder, M., Jordan, M., and Stalla, G. K. (2011). Structured assessment of hypopituitarism after traumatic brain injury and aneurysmal sub-arachnoid hemorrhage in 1242 patients: the German interdisciplinary database. J. Neurotrauma 28, 1693-1698.
81. Schneider, H. J., Schneider, M., Saller, B., Petersenn, S., Uhr, M., Husemann, B., Von Rosen, F., and Stalla, G. K. (2006). Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur. J. Endocrinol. 154,259-265.
82. Schneider, M., Schneider, H. J., and Stalla, G. K. (2005). Anterior pituitary hormone abnormalities following traumatic brain injury. J. Neurotrauma 22,937-946.
83. Schneider, M., Schneider, H. J., Yas-souridis, A., Saller, B., Von Rosen, E, and Stalla, G. K. (2008). Predictors of anterior pituitary insufficiency after traumatic brain injury. Clin. Endocrinol. (Oxf.) 68, 206-212.
84. Seeman, P. (2010).Dopamine D2 receptors as treatment targets in schizophrenia. Clin. Schizophr. Relat. Psychoses 4, 56-73.
85. Srinivasan, L., Roberts, B., Bushnik, T., Englander, J., Spain, D. A., Steinberg, G. K., Ren, L., Sandel, M. E., Al-Lawati, Z., Teraoka, J., Hoffman, A. R., and Katznel-son, L. (2009). The impact of hypopituitarism on function and performance in subjects with recent history of traumatic brain injury and aneurysmal subarach-noid haemorrhage. Brain Inj. 23, 639-648.
86. Stokes, A., and Gallagher, J. (2011). "Pituitary deficiencies in active duty military patients with a history of mild traumatic brain injury," in 3rd Federal Interagency Conference on Traumatic Brain Injury, Washington, DC.
87. Svensson, J., Bengtsson, B.-Å., Rosén, T., Odén, A., and Johannsson, G. (2004a). Malignant disease and cardiovascular morbidity in hypopi-tuitary adults with or without growth hormone replacement therapy. J. Clin. Endocrinol. Metab. 89, 3306-3312.
88. Svensson, J., Mattsson, A., Rosén, T., Wirén, L., Johannsson, G., Bengtsson, B.-Å., and Koltowska Häg-gström, M. (2004b). Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Horm. IGF Res. 14,207-215.
89. Svensson, J., Finer, N., Bouloux, P., Bevan, J., Jonsson, B., Mattsson, A. F., Lundberg, M., Harris, P. E., Koltowska-Häggström, M., and Monson, J. P. (2007). Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response. Growth Horm. IGF Res. 17, 67-76.
90. Tanielian, T. L., Jaycox, L., and RAND Corporation. (2008). Invisible Wounds of War: Psychological and Cognitive Injuries, their Consequences, and Services to Assist Recovery. Santa Monica, CA: RAND.
91. Tanriverdi, F., Agha, A., Aimaretti, G., Casanueva, F. F., Kelestimur, F., Klose, M., Masel, B. E., Pereira, A. M., Popovic, V., and Schneider, H. J. (2011). Manifesto for the current understanding and management of traumatic brain injury-induced hypopituitarism. J. Endocrinol. Invest. 34, 541-543.
92. Tanriverdi, F., Senyurek, H., Unluhizarci, K., Selcuklu, A., Casanueva, F. F., and Kelestimur, R (2006). High risk of hypopituitarism after traumatic brain injury: a prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J. Clin. Endocrinol. Metab. 91, 2105-2111.
93. Tanriverdi, F., Taheri, S., Ulutabanca, H., Caglayan, A. O., Ozkul, Y., Dun-dar, M., Selcuklu, A., Unluhizarci, K., Casanueva, F. F., and Kelestimur, F. (2008a). Apolipoprotein E3/E3 genotype decreases the risk of pituitary dysfunction after traumatic brain injury due to various causes: preliminary data. J. Neurotrauma 25, 1071-1077.
94. Tanriverdi, F., Ulutabanca, H., Unluhizarci, K., Selcuklu, A., Casanueva, R R, and Kelestimur, R (2008b). Three years prospective investigation of anterior pituitary function after traumatic brain injury: a pilot study. Clin. Endocrinol. (Oxf.) 68, 573-579.
95. Tanriverdi, F., Unluhizarci, K., Kocyigit, I., Tuna, I. S., Karaca, Z., Durak, A. C., Selcuklu, A., Casanueva, R R, and Kelestimur, R (2008c). Brief communication: pituitary volume and function in competing and retired male boxers. Ann. Intern. Med. 148, 827-831.
96. Tanriverdi, F., Unluhizarci, K., Cokse-vim, B., Selcuklu, A., Casanueva, R R, and Kelestimur, R (2007). Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism. Clin. Endocrinol. (Oxf.) 66, 360-366.
97. Tanriverdi, F., Unluhizarci, K., Karaca, Z., Casanueva, R R, and Kelestimur, F. (2010a). Hypopituitarism due to sports related head trauma and the effects of growth hormone replacement in retired amateur boxers. Pituitary 13,111-114.
98. Tanriverdi, F., Unluhizarci, K., and Kelestimur, R (2010b). Pituitary function in subjects with mild traumatic brain injury: a review of literature and proposal of a screening strategy. Pituitary 13, 146-153.
99. Terrio, H., Brenner, L. A., Ivins, B. J., Cho, J. M., Helmick, K., Schwab, K., Scally, K., Bretthauer, R., and Warden, D. (2009). Traumatic brain injury screening: preliminary findings in a US Army Brigade Combat Team. J. Head Trauma Rehabil. 24, 14-23.
100. Tomlinson, J. W., Holden, N., Hills, R. K., Wheatley, K., Clayton, R. N., Bates, A. S., Sheppard, M. C., and Stewart, P. M. (2001). Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357, 425-431.
101. Urban, R. J., Harris, P., and Masel, B. (2005). Anterior hypopituitarism following traumatic brain injury. Brain Inj. 19,349-358.
102. Van Cauter, E., Kerkhofs, M., Caufriez, A., Van Onderbergen, A., Thorner, M. O., and Copinschi, G. (1992). A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J. Clin. Endocrinol. Metab. 74, 1441-1450.
103. van der Eerden, A. W., Twickler, M. T., Sweep, R C., Beems, T., Hen-dricks, H. T., Hermus, A. R., and Vos, P. E. (2010). Should anterior pituitary function be tested during follow-up of all patients presenting at the emergency department because of traumatic brain injury? Eur. J. Endocrinol. 162, 19-28.
104. van Londen, L., Goekoop, J. G., Van Kempen, G. M. V., Frankhuijzen-Sierevogel, A. C., Wiegant, V M., Van Der Velde, E. A., and De Wied, D. (1997). Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychophar-macology 17,284-292.
105. Verhelst, J., and Abs, R. (2009). Cardiovascular risk factors in hypopituitary GH-deficient adults. Eur. J. Endocrinol. 161(Suppl. 1), S41-S49.
106. Zgaljardic, D. J., Guttikonda, S., Grady, J. J., Gilkison, C. R., Mossberg, K. A., High, W. M. Jr., Masel, B. E., and Urban, R. J. (2011). Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing. Clin. Endocrinol. (Oxf.) 74, 365-369.
107. Ziebell, J. M., and Morganti-Kossmann, M. C. (2010). Involvement of pro-and anti-inflammatory cytokines and chemokines in the pathophys-iology of traumatic brain injury. Neurotherapeutics 7, 22-30.